• PreScission Protease (PSP): Tag Cleavage Guide

  2026-09-15

  PreScission Protease (PSP) is a recombinant HRV 3C protease fusion enzyme for removing compatible affinity tags from recombinant proteins while supporting recovery of the target protein. It should be used only when the required recognition sequence is present and accessible; it is not a general-purpose protease for broad proteolysis or non-canonical cleavage sites.

• NADPH Oxidase ROS and Arterial Contraction

  2026-09-15

  The reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream route by which NADPH oxidase-derived reactive oxygen species promote contraction in saphenous arteries from early postnatal rats. Its inhibitor-interaction design separates this mechanism from Rho-kinase, PKC, and Src-kinase signaling, providing a useful framework for interpreting kinase controls in vascular experiments.

• Testosterone Bounce in Degarelix-Treated Prostate Cancer

  2026-09-14

  A retrospective study identified testosterone bounce—recovery above 20 ng/dL after achieving a lower nadir—as a prognostic marker associated with longer overall and cancer-specific survival in degarelix-treated prostate cancer. The finding supports longitudinal testosterone monitoring alongside PSA, while the absence of an observed progression-free survival association argues against using testosterone bounce as a standalone treatment-response endpoint.

• Hexetidine (NSC-17764) Assay Workflow Guide

  2026-09-14

  Build reproducible planktonic, biofilm, and oral-microbe assays with Hexetidine while accounting for strain-specific susceptibility, solvent behavior, and transient salivary activity. The workflow also shows how to translate laboratory findings into realistic dental plaque reduction and gingivitis treatment questions without overstating clinical equivalence.

• CLCC1 and Herpesvirus Nuclear Egress

  2026-09-13

  A 2024 bioRxiv study identifies the host factor CLCC1 as essential for the membrane-fusion step that releases herpesvirus capsids from the nucleus. CRISPR screening and cellular phenotyping connect CLCC1 loss to perinuclear vesicle accumulation, impaired nuclear pore insertion, and reduced HSV-1 production, revealing a conserved membrane-remodeling process rather than a purely viral mechanism.

• Epinephrine Bitartrate: Better Adrenergic Assays

  2026-09-12

  Epinephrine Bitartrate is a powerful tool for studying receptor activation, affinity, and assay reproducibility. This guide connects its pharmacology with an open-tubular capillary electrochromatography method to help researchers design more interpretable adrenergic experiments.

• HyperScript Reverse Transcriptase for RNA Workflows

  2026-09-11

  The HyperScript First-Strand cDNA Synthesis Kit is designed for demanding RNA template reverse transcription, including low-input samples, structured transcripts, and long cDNA targets. Its flexible primer system helps researchers move from total RNA or poly(A)+ RNA to dependable PCR amplification and qPCR reaction workflows.

• Meropenem trihydrate in Cell Assays

  2026-09-11

  Learn how Meropenem trihydrate, SKU B1217, can help separate antibacterial effects from assay artifacts in cell viability and infection models. This scenario-based guide combines practical formulation guidance with recent metabolomics evidence for carbapenem-resistance studies.

• Drosophila Keap1 Nuclear Condensates Under Stress

  2026-09-10

  A 2026 study in Antioxidants shows that Drosophila Keap1 assembles stable nuclear condensates after oxidative stress, linking its stress-response role with nuclear organization. Live imaging, FRAP, domain analysis, and in vitro reconstitution identify the N- and C-terminal regions, including intrinsically disordered regions, as key determinants of this behavior.

• Epinephrine Bitartrate: Research Workflows

  2026-09-10

  Epinephrine Bitartrate enables controlled studies of vascular tone, cardiac signaling, airway responses, and adrenergic receptor biology across concentration-resolved assays. This guide translates its non-selective pharmacology into practical workflows while adapting supply-stewardship lessons from local-anesthetic research without treating the formulations as interchangeable.

• SERT–nNOS Blockade and Rapid Antidepressant Effects

  2026-09-09

  The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by screening for compounds that disrupt the serotonin transporter–neuronal nitric oxide synthase interaction in the dorsal raphe nucleus. Its combination of mBRET screening, stress-model pharmacology, molecular analysis, and resting-state fMRI connects target engagement with serotonergic circuit and behavioral changes, while leaving clinical translation unresolved.

• Hoechst 33342/PI Double Staining Kit Guide

  2026-09-09

  The Hoechst 33342/PI Double Staining Kit provides a dual-fluorescence workflow for distinguishing nuclear chromatin changes from loss of cell membrane integrity in cultured samples. It is intended for research use in fluorescence-based cell death studies, not for diagnostic, clinical, or medical decision-making.

• Angiotensin I Workflows for RAS Research

  2026-09-08

  Build reproducible renin-angiotensin system experiments around Angiotensin I as a defined substrate for ACE conversion, cardiovascular pathway studies, and antihypertensive screening. The workflow also shows how recent peptide-binding findings can guide carefully controlled cross-domain assays without confusing precursor activity with downstream Ang II effects.

• Engineering a Single-Component Bitespiramycin Strain

  2026-09-08

  Ma et al. simplified bitespiramycin biosynthesis by deleting part of the sspA 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1. The resulting WSJ-2 strain preferentially produced 400-isovalerylspiramycin I, illustrating how targeted pathway engineering can reduce antibiotic component complexity and improve downstream characterization.

• HA-LNP PTEN mRNA for Transdermal Immunotherapy

  2026-09-07

  The reference study develops a hyaluronate-conjugated lipid nanoparticle in which HA-DMG replaces conventional PEG-lipid functions while enabling CD44-oriented delivery of PTEN mRNA through skin. In a melanoma model, topical PTEN mRNA@HA-LNP restored tumor-suppressor expression, promoted immunogenic cell death, activated antitumor immunity, and reduced tumor growth with limited reported toxicity.

8113 records 1/541 page Next 12345 下5页 Last page